Clinical Trials Logo

Middle Age clinical trials

View clinical trials related to Middle Age.

Filter by:
  • None
  • Page 1

NCT ID: NCT05281978 Completed - Exercise Clinical Trials

One Step at a Time: An Intervention to Reduce Sedentary Behavior Among Working Adults

Start date: April 25, 2022
Phase: N/A
Study type: Interventional

The proposed study will test the preliminary efficacy of a novel 12-week social cognitive theory-based intervention that will target reducing daily sitting time and increasing exercise participation among middle-aged working adults. This is a population highly susceptible to excessive sedentary time and low levels of exercise engagement. This two-arm randomized controlled trial (RCT) will examine the preliminary efficacy of decreasing sedentary time in addition to increasing moderate-vigorous intensity physical activity (MVPA) engagement, compared to a group which only receives MVPA promotion.

NCT ID: NCT05092932 Completed - Healthy Clinical Trials

Walking Aid Assessment, Arm Strength and Force Under the Foot in Normal Subjects

Start date: January 1, 2020
Phase:
Study type: Observational

This study will collect biomedical performance data on walking characteristics in normal, healthy people when walking with walking aids and when walking unaided. Data will be used for independent reporting and for comparison to matched people with pathological conditions. Data collected will including walking ability, balance, force under the feet when walking and muscle strength.

NCT ID: NCT03962517 Completed - Aged Clinical Trials

Effect of GEMS-H on Locomotor Function in Adults

Start date: May 28, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effect of training with the Gait Enhancing and Motivating System-Hip (GEMS-H) vs. training without the GEMS-H on locomotor function in adults. The investigator hypothesizes that long-term GEMS-H use would improve locomotor function. Specifically, individuals in the GEMS-H group will show faster gait speed compared to those in the control group.

NCT ID: NCT02463084 Completed - Clinical trials for Mild Cognitive Impairment

Macronutrient Effects on Alzheimer's Disease (MEAL-2)

MEAL-2
Start date: March 2013
Phase: N/A
Study type: Interventional

This study compares the effects of a one-month diet high in saturated fat (SF), glycemic index (GI), and salt (Na+) to a diet low in these nutritional parameters on memory and other cognitive functions, on MRI measures of brain structure, function, and perfusion, as well as on blood and cerebrospinal fluid levels of amyloid-beta (Aβ), insulin, lipids (total cholesterol, HDL, LDL, oxidized LDL, and triglycerides), cytokines, apolipoprotein E (ApoE), apolipoprotein J, cortisol, soluble low density lipoprotein receptor-related protein (sLRP), and glucose in middle-aged adults (45-65 years of age) with normal cognition or mild cognitive impairment.